Identification and validation of NFIA as a novel prognostic marker in renal cell carcinoma.

de Alwis, Roger; Schoch, Sarah; Islam, Mazharul; Möller, Christina; Ljungberg, Börje; Axelson, Håkan

de Alwis, Roger; Schoch, Sarah; Islam, Mazharul; Möller, Christina; Ljungberg, Börje; Axelson, Håkan.

Afiliación

de Alwis R; Division of Translational Cancer Research, Department of Laboratory Medicine Lund University, Lund, Sweden.
Schoch S; Division of Translational Cancer Research, Department of Laboratory Medicine Lund University, Lund, Sweden.
Islam M; Division of Translational Cancer Research, Department of Laboratory Medicine Lund University, Lund, Sweden.
Möller C; Division of Translational Cancer Research, Department of Laboratory Medicine Lund University, Lund, Sweden.
Ljungberg B; Department of Surgical and Perioperative Sciences, Urology and Andrology, Umeå University, Umeå, Sweden.
Axelson H; Division of Translational Cancer Research, Department of Laboratory Medicine Lund University, Lund, Sweden.

J Pathol Clin Res ; 9(4): 261-272, 2023 07.

Article en En | MEDLINE | ID: mdl-36947439

Asunto(s)

Carcinoma de Células Renales; Neoplasias Renales; Humanos; Carcinoma de Células Renales/patología; Neoplasias Renales/patología; Pronóstico; Análisis de Supervivencia; Núcleo Celular/patología; Factores de Transcripción NFI/genética

Palabras clave

biomarker; cancer-specific survival; immunohistochemistry; renal cell carcinoma

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Neoplasias Renales Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Humans Idioma: En Revista: J Pathol Clin Res Año: 2023 Tipo del documento: Article País de afiliación: Suecia Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google